Biotech

All Articles

Daiichi pays Merck $170M to create lung cancer T-cell engager treaty

.Merck &amp Co. has actually quickly gotten back several of the prices of its Javelin Therapies acqu...

BioMarin standstills preclinical genetics treatment for heart condition

.After BioMarin carried out a springtime tidy of its own pipeline in April, the business has actuall...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks handle

.Huge Pharmas continue to be stuck to the tip of molecular glue degraders. The current business to o...

Life science credit scores company unveils with $600M

.A brand new global life science debt firm, termed Symbiotic Funding, has actually raised more than ...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing one more big bet coming from the Caforio era, canceling a package for...

Nuvation halts BET inhibitor after thinking about period 1 data

.After checking out at period 1 information, Nuvation Bio has determined to stop deal with its one-t...

' Professional intuitiveness' led FDA advisors to support Zevra's uncommon condition med

.Zevra Therapeutics' rare illness medicine seems to be to become on the road to confirmation this fa...

Pfizer takes $230M attacked after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics therapy breakdown has gone a $230 mill...

AC Immune sees 'landmark' possible in Alzheimer's medicine records

.After greater than twenty years of focus on neurodegenerative diseases, Swiss biotech a/c Invulnera...

GSK goes down ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has actually junked a phase 2 individual papillomavirus (HPV) injection from its own pipe after...